Our Company .
Solvotrin Therapeutics is an Irish healthcare development company that enhances established therapies through innovative science with patent protection.
Headquartered in Co. Cork, Ireland, Solvotrin has a team of 19 people with the R&D team members located at Trinity College Dublin.
Founders & Investors .
Solvotrin Therapeutics was founded by CEO Pat O Flynn. Pat is a highly successful entrepreneur with over 20 years’ experience and an educational background in Engineering.
Founded in partnership with Professor Mark Ledwidge and Professor John Gilmer, Solvotrin works closely with a network of investors to drive the growth of Solvotrin Therapeutics. We blend research, data, technology, and investment to unlock opportunities and deliver strategic solutions across multiple markets.
Our Strategy .
Partners .
Ireland
Pharmed Group
China
Nuance Pharma
USA
The Market Performance Group
USA
Ortho Molecular
Malta
MGC Distributors
Greece
Bionat
New Zealand
USL
Serbia
Proton
Bulgaria
Bulvax
Germany
Eb Vertriebs
Middle East | Africa
MMDS